{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:20Z","timestamp":1793390840423,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.beem.2026.102129","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:31:08Z","timestamp":1779319868000},"page":"102129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Type 2 diabetes and obesity in South Asian patients with polyendocrine metabolic ovarian syndrome: The emerging role of metabolomics"],"prefix":"10.1016","volume":"40","author":[{"given":"Pramod P.","family":"Wangikar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthana","family":"Vinodkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushboo","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash Vellore","family":"Sunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Sahasrabuddhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharati","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.beem.2026.102129_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","article-title":"Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis","volume":"310","author":"Salari","year":"2024","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.beem.2026.102129_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.beem.2026.102129_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib5","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.beem.2026.102129_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.beem.2026.102129_bib7","series-title":"Endotext. South Dartmouth (MA)","article-title":"Thin Fat Obesity: The Tropical Phenotype of Obesity","author":"Kapoor","year":"2000"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1753-4887.2001.tb01898.x","article-title":"The insulin resistance epidemic in india: fetal origins, later lifestyle, or both","volume":"59","author":"Yajnik","year":"2009","journal-title":"Nutr Rev"},{"issue":"9","key":"10.1016\/j.beem.2026.102129_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2025.103019","article-title":"Prevalence of polycystic ovarian syndrome in South Asian countries and 21 global regions with Sociodemographic index: a systematic analysis of the Global Burden of Disease (1990\u20132021","volume":"54","author":"Satapathy","year":"2025","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"4","key":"10.1016\/j.beem.2026.102129_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4103\/ijmr.IJMR_1937_17","article-title":"Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India","volume":"150","author":"Ganie","year":"2019","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050","volume":"41","author":"Duncan","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib12","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138","article-title":"Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria","volume":"93","author":"Huang","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.beem.2026.102129_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.beem.2026.102129_bib15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.fertnstert.2014.01.049","article-title":"Complete phenotypic and metabolic profiles of a large consecutive cohort of untreated Korean women with polycystic ovary syndrome","volume":"101","author":"Kim","year":"2014","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib16","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib17","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib18","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2008-2836","article-title":"Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Sir-Petermann","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102129_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000494899","article-title":"utero androgen excess: a developmental commonality preceding polycystic ovary syndrome?","volume":"53","author":"Abbott","year":"2019","journal-title":"Front Horm Res"},{"key":"10.1016\/j.beem.2026.102129_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","volume":"12","author":"Khan","year":"2019","journal-title":"Appl Clin Genet"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib21","doi-asserted-by":"crossref","first-page":"R235","DOI":"10.1530\/REP-13-0351","article-title":"Mutations and polymorphisms in FSH receptor: functional implications in human reproduction","volume":"146","author":"Desai","year":"2013","journal-title":"Reproduction"},{"issue":"12","key":"10.1016\/j.beem.2026.102129_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.beem.2026.102129_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11154-012-9214-8","article-title":"Fetal programming: maternal nutrition and role of one-carbon metabolism","volume":"13","author":"Yajnik","year":"2012","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2026.102129_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000341682","author":"Barber","year":"2013","journal-title":"Genet Polycystic Ovary Syndr"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","article-title":"An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm Res Paediatr"},{"issue":"sup6","key":"10.1016\/j.beem.2026.102129_bib26","doi-asserted-by":"crossref","first-page":"588S","DOI":"10.1080\/07315724.2004.10719428","article-title":"The developmental origins of adult disease","volume":"23","author":"Barker","year":"2004","journal-title":"J Am Coll Nutr"},{"issue":"8","key":"10.1016\/j.beem.2026.102129_bib27","article-title":"Insulin resistance and body fat distribution in South Asian men compared to caucasian men","volume":"2","author":"Chandalla","year":"2007","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.beem.2026.102129_bib28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","article-title":"Metabolic phenotyping in health and disease","volume":"134","author":"Holmes","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.beem.2026.102129_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cmet.2021.02.008","article-title":"Passing on PCOS: new insights into its epigenetic transmission","volume":"33","author":"Abbott","year":"2021","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.beem.2026.102129_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.2002.01603.x","article-title":"Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference","volume":"57","author":"Wijeyaratne","year":"2002","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2026.102129_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.2002.01603.x","article-title":"Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference","volume":"57","author":"Wijeyaratne","year":"2002","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102129_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajcn\/84.2.289","article-title":"Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases1\u20133","volume":"84","author":"Popkin","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"10.1016\/j.beem.2026.102129_bib33","doi-asserted-by":"crossref","first-page":"e1077","DOI":"10.1016\/S2214-109X(18)30357-7","article-title":"Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1\u00b79 million participants","volume":"6","author":"Guthold","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.beem.2026.102129_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/ijem.ijem_680_25","article-title":"ESI Clinical Practice Guidelines for the evaluation and management of obesity in India \u2013 an update (2025)","volume":"29","author":"Madhu","year":"2025","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102129_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102129_bib36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ajog.2017.01.003","article-title":"Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype","volume":"216","author":"Engmann","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"26","key":"10.1016\/j.beem.2026.102129_bib37","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3748\/wjg.v20.i26.8351","article-title":"Nonalcoholic fatty liver disease and polycystic ovary syndrome","volume":"20","author":"Vassilatou","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.beem.2026.102129_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ajog.2017.01.003","article-title":"Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype","volume":"216","author":"Engmann","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.beem.2026.102129_bib39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40200-018-0371-5","article-title":"Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach","volume":"17","author":"Toosy","year":"2018","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.beem.2026.102129_bib40","first-page":"16","article-title":"Analyzing and evaluating the metabolic and endocrine characteristics between lean and obese patients with polycystic ovary syndrome: a systemic review and meta-analysis","author":"Zheng","year":"2025","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.31083\/j.ceog5106142","article-title":"Lean polycystic ovary syndrome: a narrative review","volume":"51","author":"Elnashar","year":"2024","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.beem.2026.102129_bib42","first-page":"12","article-title":"Comparing lean and obese PCOS in different PCOS phenotypes: evidence that the body weight is more important than the rotterdam phenotype in influencing the metabolic status","author":"Carmina","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.beem.2026.102129_bib43","series-title":"Endotext. South Dartmouth (MA)","article-title":"Thin Fat Obesity: The Tropical Phenotype of Obesity","author":"Kapoor","year":"2000"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1753-4887.2001.tb01898.x","article-title":"The insulin resistance epidemic in india: fetal origins, later lifestyle, or both","volume":"59","author":"Yajnik","year":"2009","journal-title":"Nutr Rev"},{"issue":"10","key":"10.1016\/j.beem.2026.102129_bib45","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 International evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib46","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1373\/clinchem.2011.176396","article-title":"Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS","volume":"58","author":"Escobar-Morreale","year":"2012","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib47","article-title":"Alterations of sphingolipid metabolism in different types of polycystic ovary syndrome","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2026.102129_bib48","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.csbj.2020.06.023","article-title":"Meta-analysis of gene expression profiles of lean and obese PCOS to identify differentially regulated pathways and risk of comorbidities","volume":"18","author":"Idicula-Thomas","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.beem.2026.102129_bib49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0041-1729841","article-title":"Metabolomic biomarkers in polycystic ovary syndrome: a review of the evidence","author":"Alesi","year":"2021","journal-title":"Semin Reprod Med Theme Med Publ Inc"},{"issue":"8","key":"10.1016\/j.beem.2026.102129_bib50","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3390\/diagnostics12081922","article-title":"Hirsutism, normal androgens and diagnosis of PCOS","volume":"12","author":"Spritzer","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.beem.2026.102129_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2013.12.018","article-title":"Metabolomics in polycystic ovary syndrome","author":"Murri","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.beem.2026.102129_bib52","first-page":"235","article-title":"Searching for the primary metabolic alterations of polycystic ovary syndrome by application of the untargeted metabolomics approach","author":"Rajska","year":"2023","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.beem.2026.102129_bib53","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1021\/acs.jproteome.4c00937","article-title":"The role of aromatic amino acids in polycystic ovary syndrome through patients\u2019 blood metabolic profiling: a systematic review of the past five years","author":"Gkantzos","year":"2025","journal-title":"J Proteome Res Am Chem Soc"},{"key":"10.1016\/j.beem.2026.102129_bib54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/msb.2012.43","article-title":"Novel biomarkers for pre-diabetes identified by metabolomics","volume":"8","author":"Wang-Sattler","year":"2012","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.beem.2026.102129_bib55","article-title":"Biomarkers in polycystic ovary syndrome","volume":"36","author":"Huffman","year":"2023","journal-title":"Curr Opin Physiol"},{"issue":"5","key":"10.1016\/j.beem.2026.102129_bib56","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1021\/pr3000317","article-title":"Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients","volume":"11","author":"Sun","year":"2012","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib57","article-title":"Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism and masculinization of intermediate metabolism in women with polycystic ovary syndrome (PCOS)","volume":"14","author":"Escobar-Morreale","year":"2023","journal-title":"Biol Sex Differ"},{"issue":"2","key":"10.1016\/j.beem.2026.102129_bib58","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/pr401130w","article-title":"Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry","volume":"13","author":"Zhao","year":"2014","journal-title":"J Proteome Res"},{"issue":"16","key":"10.1016\/j.beem.2026.102129_bib59","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1007\/s00216-015-8670-x","article-title":"Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach","volume":"407","author":"Dong","year":"2015","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"10.1016\/j.beem.2026.102129_bib60","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mrd.23104","article-title":"Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry","volume":"86","author":"Jia","year":"2019","journal-title":"Mol Reprod Dev"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib61","doi-asserted-by":"crossref","DOI":"10.1186\/s12920-021-01058-y","article-title":"Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome","volume":"14","author":"Yu","year":"2021","journal-title":"BMC Med Genom"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-025-01842-9","article-title":"Mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome","volume":"18","author":"\u00d6zer","year":"2025","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.beem.2026.102129_bib63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.metabol.2017.03.002","article-title":"Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome","volume":"71","author":"Chang","year":"2017","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib64","article-title":"Alterations of sphingolipid metabolism in different types of polycystic ovary syndrome","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010108","article-title":"Specific alteration of branched-chain amino acid profile in polycystic ovary syndrome","volume":"11","author":"Paczkowska","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.beem.2026.102129_bib66","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1152\/ajpendo.00532.2018","article-title":"Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome","volume":"316","author":"Cree-Green","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102129_bib67","first-page":"15","article-title":"Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment","author":"Zhao","year":"2024","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2026.102129_bib68","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1039\/C6MB00420B","article-title":"Serum metabolomics of Indian women with polycystic ovary syndrome using 1H NMR coupled with a pattern recognition approach","volume":"12","author":"Roychoudhury","year":"2016","journal-title":"Mol Biosyst"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-025-00985-6","article-title":"Comparing the metabolomic landscape of polycystic ovary syndrome within urban and rural environments","volume":"5","author":"Patel","year":"2025","journal-title":"Commun Med"},{"key":"10.1016\/j.beem.2026.102129_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113262","article-title":"Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes","volume":"185","author":"Zhou","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.beem.2026.102129_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2015.06.008","article-title":"Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS","volume":"448","author":"Wang","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.beem.2026.102129_bib72","first-page":"647","article-title":"Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome","author":"Yang","year":"2022","journal-title":"Anal Biochem"},{"issue":"14","key":"10.1016\/j.beem.2026.102129_bib73","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.3390\/ijms21144853","article-title":"Metabolomic insight into polycystic ovary syndrome\u2014an overview","volume":"21","author":"Rajska","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-019-0490-y","article-title":"Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry","volume":"17","author":"Sun","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2026.102129_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081810","article-title":"Metabolomic analysis of follicular fluid in normal-weight patients with polycystic ovary syndrome","volume":"12","author":"Yu","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.beem.2026.102129_bib76","first-page":"13","article-title":"Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: a pilot study","author":"Ding","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2026.102129_bib77","first-page":"1","article-title":"Identification of the Metabolomics Signature of Human Follicular Fluid from PCOS Women with Insulin Resistance","volume":"2022","author":"Liu","year":"2022"},{"key":"10.1016\/j.beem.2026.102129_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117860","article-title":"Biomarkers identification in follicular fluid in relation to live birth in in vitro fertilization of women with polycystic ovary syndrome in different subtypes by using UPLC-MS method","volume":"557","author":"Liu","year":"2024","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.beem.2026.102129_bib79","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mrd.23111","article-title":"Nontargeted metabolomic analysis of skeletal muscle in a dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome","volume":"86","author":"Shen","year":"2019","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.beem.2026.102129_bib80","first-page":"14","article-title":"Differences in metabonomic profiles of abdominal subcutaneous adipose tissue in women with polycystic ovary syndrome","author":"Di","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2026.102129_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1700191","article-title":"Research progress of gut microbiota and its metabolites in polycystic ovary syndrome","author":"Qin","year":"2025","journal-title":"Front Endocrinol Front Media SA"},{"key":"10.1016\/j.beem.2026.102129_bib82","first-page":"11","article-title":"Correlation between fecal metabolomics and gut microbiota in obesity and polycystic ovary syndrome","author":"Zhou","year":"2020","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib83","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-024-01550-w","article-title":"Gut microbiota and gut-derived metabolites are altered and associated with dietary intake in women with polycystic ovary syndrome","volume":"17","author":"da Silva","year":"2024","journal-title":"J Ovarian Res"},{"issue":"12","key":"10.1016\/j.beem.2026.102129_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11120845","article-title":"Profile of bile acid metabolomics in the follicular fluid of pcos patients","volume":"11","author":"Yang","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25041-4","article-title":"Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study","volume":"12","author":"Yu","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2026.102129_bib86","first-page":"1","article-title":"Metabolomic insight into polycystic ovary syndrome\u2014an overview","author":"Rajska","year":"2020","journal-title":"Int J Mol Sci MDPI AG"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib87","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12967-024-05167-x","article-title":"Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome","volume":"22","author":"Qian","year":"2024","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010108","article-title":"Specific alteration of branched-chain amino acid profile in polycystic ovary syndrome","volume":"11","author":"Paczkowska","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.beem.2026.102129_bib89","first-page":"2022","article-title":"Combined transcriptomic and metabolomic analysis of women with polycystic ovary syndrome","author":"Tian-Min","year":"2022","journal-title":"Dis Markers"},{"key":"10.1016\/j.beem.2026.102129_bib90","first-page":"15","article-title":"Multi-omics approach to reveal follicular metabolic changes and their effects on oocyte competence in PCOS patients","author":"Chen","year":"2024","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib91","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000548","article-title":"Polycystic ovary syndrome: pathophysiology and therapeutic opportunities","volume":"2","author":"Dong","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.beem.2026.102129_bib92","first-page":"2022","article-title":"Identification of the metabolomics signature of human follicular fluid from PCOS women with insulin resistance","author":"Liu","year":"2022","journal-title":"Dis Markers"},{"key":"10.1016\/j.beem.2026.102129_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106919","article-title":"Role of bile acids in the pathogenesis and metabolic abnormalities of polycystic ovary syndrome (PCOS","volume":"257","author":"Wang","year":"2026","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.beem.2026.102129_bib94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11306-020-1642-y","article-title":"Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome","volume":"16","author":"Zhang","year":"2020","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib95","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1741-7015-10-153","article-title":"Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis","volume":"10","author":"Zhao","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.beem.2026.102129_bib96","first-page":"12","article-title":"How to screen and prevent metabolic syndrome in patients of PCOS early: implications from metabolomics","author":"Zhao","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2026.102129_bib97","first-page":"10","article-title":"The effects of pro-, pre-, and synbiotics supplementation on polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials","author":"Talebi","year":"2023","journal-title":"Front Nutr"},{"issue":"10","key":"10.1016\/j.beem.2026.102129_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108834","article-title":"The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: a meta-analysis of randomized controlled trials","volume":"38","author":"Austreg\u00e9silo de Athayde De Hollanda Morais","year":"2024","journal-title":"J Diabetes Complicat"},{"issue":"9","key":"10.1016\/j.beem.2026.102129_bib99","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/metabo14090483","article-title":"Machine learning-based plasma metabolomics in liraglutide-treated type 2 diabetes mellitus patients and diet-induced obese mice","volume":"14","author":"Park","year":"2024","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03355-2","article-title":"Proteomic changes upon treatment with semaglutide in individuals with obesity","volume":"31","author":"Maretty","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41387-022-00213-3","article-title":"Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes","volume":"12","author":"Vanweert","year":"2022","journal-title":"Nutr Diabetes"},{"issue":"6","key":"10.1016\/j.beem.2026.102129_bib102","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/joim.20090","article-title":"Metabolomics in cardiometabolic diseases: Key biomarkers and therapeutic implications for insulin resistance and diabetes","volume":"297","author":"Rizo-Roca","year":"2025","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.beem.2026.102129_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-11970-7","article-title":"Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC-MS\/MS technique","volume":"12","author":"Hosseinkhani","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2026.102129_bib104","first-page":"16","article-title":"Metabolomics uncovers the diabetes metabolic network: from pathophysiological mechanisms to clinical applications","author":"Xu","year":"2025","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102129_bib105","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194742","article-title":"GLP-1RA precision medicine in people with type 2 diabetes: current insights and future prospects","volume":"136","author":"Cardoso","year":"2026","journal-title":"J Clin Investig"},{"key":"10.1016\/j.beem.2026.102129_bib106","doi-asserted-by":"crossref","unstructured":"Teede H.J., Bahri Khomami M., Morman R., Laven J.S.E., Joham A.E., Costello M.F., et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet 2026 (in press). doi:10.1016\/S0140-6736(26)00717-8.","DOI":"10.18370\/2309-4117.2026.83.79-87"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:12:17Z","timestamp":1785885137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X26000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1521690X26000515"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102129","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes and obesity in South Asian patients with polyendocrine metabolic ovarian syndrome: The emerging role of metabolomics","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102129"}}